This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Emiko Tagami: Innovator in Therapeutic Drug Development
Introduction
Emiko Tagami is a prominent inventor based in Otone, Japan. She has made significant contributions to the field of therapeutic drugs, particularly in the development of arylglycinamide derivatives. Her work focuses on addressing medical conditions such as urinary incontinence and pollakiuria.
Latest Patents
Emiko Tagami holds a patent for "Arylglycinamide derivatives and preparative processes therefor." This patent describes arylglycinamide derivatives represented by a general formula, which includes various substituents and functional groups. These compounds are recognized for their effectiveness as therapeutic drugs for dysurias, providing innovative solutions for patients suffering from these conditions.
Career Highlights
Emiko Tagami is associated with Kyorin Pharmaceutical Co., Ltd., where she continues to advance her research and development efforts. Her dedication to innovation in the pharmaceutical industry has positioned her as a key figure in therapeutic drug development.
Collaborations
Emiko has collaborated with notable colleagues, including Hiroyuki Miyachi and Mitsuru Segawa. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Emiko Tagami's contributions to the field of therapeutic drugs exemplify her commitment to innovation and improving patient care. Her work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile